Post-approval studies (Phase 4)Looking for participantsNCT07158164
What this trial is testing
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Who this might be right for
Colorectal NeoplasmsBreast NeoplasmsHead and Neck Neoplasms+1 more
Rutgers, The State University of New Jersey 100